X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results

Go back to X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results
(NASDAQ: XFOR) Delayed: 3.46 -0.05 (1.42%)
Previous Close $3.51    52 Week High
Open $3.56    52 Week Low
Day High $3.59    P/E N/A 
Day Low $3.41    EPS
Volume 469,882